Enterprise Value
16.79M
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
4.43%
Insider Ownership
0.13%
Institutional Own.
83.66%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EDP1815 Details Psoriasis | Phase 3 Initiation | |
EDP1815 Details COVID-19 | Phase 2/3 Interim update | |
EDP2939 Details Psoriasis | Phase 2 Data readout | |
EDP1815 Details Atopic dermatitis | Failed Discontinued | |
EDP1867 Details Atopic dermatitis | Failed Discontinued |